TerminatedNCT04368039
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Device studyAges 15–35United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 15 years to 35 years.
- Listed locations
- ColumbusSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 4, 2019
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 3
- Sponsor
- Nicholas Breitborde
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- From 15 Years to 35 Years
- Official registry ID
- NCT04368039
- Official title
Show the full official title
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Columbus
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nicholas Breitborde.
Who can participate?
Listed age limits: 15 years to 35 years.
Is this study still recruiting?
The registry lists this study as terminated.
